GlassScriptPhysician profile
Gregory P Larsen
NPI 1548497860
$10,267.85
in general payments reported to CMS, 2019-2025
33 companies · $4,392 in 2025
The $4,392 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,890 · 2020: $174 · 2021: $298 · 2022: $1,621 · 2023: $1,254 · 2024: $640 · 2025: $4,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,903 · Travel and Lodging: $2,343 · Consulting Fee: $872 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,902.53 |
| Travel and Lodging | $2,343.37 |
| Consulting Fee | $872.00 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $1,992.49 | 2025 | Illuccix |
| Neotract INC. | $1,935.48 | 2019-2020 | |
| Teleflex LLC | $1,743.52 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,211.15 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $924.03 | 2025 | |
| Mission Medical Distribution, LLC | $389.51 | 2025 | |
| Astellas Pharma US INC | $238.07 | 2019-2025 | |
| Photocure INC | $199.86 | 2024 | Cysview |
| Pfizer INC. | $190.70 | 2019-2025 | |
| Boston Scientific Corporation | $189.12 | 2022-2024 | Ams 700 |
| Ferring Pharmaceuticals INC. | $184.84 | 2025 | Adstiladrin |
| Cook Medical LLC | $151.55 | 2020-2024 | Litho 150 |
| Sumitomo Pharma America, INC. | $138.30 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Scientific Affairs, LLC | $96.59 | 2024 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $89.08 | 2025 | Keytruda, Lynparza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $82.63 | 2022-2025 | |
| Endo USA, INC. | $53.62 | 2025 | Xiaflex |
| Coloplast Corp | $53.31 | 2021-2025 | |
| Karl Storz Endoscopy-America | $51.52 | 2022-2025 | |
| Abbvie INC. | $34.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $33.85 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $33.72 | 2025 | Lynparza |
| Conmed Corporation | $32.63 | 2024 | Airseal |
| Immunitybio, INC. | $27.73 | 2025 | |
| Olympus America INC. | $27.27 | 2024 | Itind System |
| Calyxo, INC. | $25.44 | 2025 | Cvac Aspiration System |
| Hollister Incorporated | $24.10 | 2023 | Infyna Chic |
| 180 Medical, INC. | $21.76 | 2024 | |
| Mission Pharmacal Company | $21.54 | 2019 | |
| Tolmar, INC. | $20.19 | 2025 | Jatenzo, Eligard |
| Accord Healthcare, INC. | $17.93 | 2025 | |
| Urovant Sciences INC | $17.42 | 2022 | |
| Progenics Pharmaceuticals, INC. | $14.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.